Review



her2 t her2  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc her2 t her2
    Her2 T Her2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 474 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2 t her2/product/Cell Signaling Technology Inc
    Average 96 stars, based on 474 article reviews
    her2 t her2 - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    99
    ATCC t47d er her2 breast cancer cells
    T47d Er Her2 Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t47d er her2 breast cancer cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    t47d er her2 breast cancer cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    93
    InvivoGen her2 independent t cell activation
    Her2 Independent T Cell Activation, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2 independent t cell activation/product/InvivoGen
    Average 93 stars, based on 1 article reviews
    her2 independent t cell activation - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc her2 t her2
    Her2 T Her2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2 t her2/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    her2 t her2 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    99
    ATCC t47d her2
    T47d Her2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t47d her2/product/ATCC
    Average 99 stars, based on 1 article reviews
    t47d her2 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Bellicum Inc her2-targeted dual switch car-t cells bpx-603
    Clinical trials combining CD8 + T cells with CSC targeting
    Her2 Targeted Dual Switch Car T Cells Bpx 603, supplied by Bellicum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2-targeted dual switch car-t cells bpx-603/product/Bellicum Inc
    Average 90 stars, based on 1 article reviews
    her2-targeted dual switch car-t cells bpx-603 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Nagai Nori USA INC her2-targeting t-dxd
    Clinical trials combining CD8 + T cells with CSC targeting
    Her2 Targeting T Dxd, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2-targeting t-dxd/product/Nagai Nori USA INC
    Average 90 stars, based on 1 article reviews
    her2-targeting t-dxd - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    99
    ATCC her2 0 breast cancer t47d cell lines
    Clinical trials combining CD8 + T cells with CSC targeting
    Her2 0 Breast Cancer T47d Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/her2 0 breast cancer t47d cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    her2 0 breast cancer t47d cell lines - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Fate Therapeutics ft825/ono-8250 (anti-her2 icar-t
    Clinical trials of iPSC-derived CAR-modified cells.
    Ft825/Ono 8250 (Anti Her2 Icar T, supplied by Fate Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ft825/ono-8250 (anti-her2 icar-t/product/Fate Therapeutics
    Average 90 stars, based on 1 article reviews
    ft825/ono-8250 (anti-her2 icar-t - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Clinical trials combining CD8 + T cells with CSC targeting

    Journal: Journal of Translational Medicine

    Article Title: New insights on anti-tumor immunity of CD8 + T cells: cancer stem cells, tumor immune microenvironment and immunotherapy

    doi: 10.1186/s12967-025-06291-y

    Figure Lengend Snippet: Clinical trials combining CD8 + T cells with CSC targeting

    Article Snippet: NCT04650451 , Bellicum Pharmaceuticals , Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors , HER2 , GC、BC , Phase 1/2 , 220 , , Recruiting.

    Techniques: Clinical Proteomics, Activity Assay, Immunopeptidomics

    Clinical trials of iPSC-derived CAR-modified cells.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

    doi: 10.3389/fcell.2024.1491282

    Figure Lengend Snippet: Clinical trials of iPSC-derived CAR-modified cells.

    Article Snippet: The ICAR-T pipeline of Fate Therapeutics comprises FT819 (anti-CD19 iCAR-T), FT825/ONO-8250 (anti-HER2 iCAR-T), and FT836 (anti-MICA/B ICAR-T), except for the last one two others have been entered clinical trials.

    Techniques: